OPKO Health (NasdaqGS:OPK) Q3 2025 Earnings Call October 29, 2025 04:30 PM ET Speaker5Good afternoon and welcome to the OPKO Health third quarter 2025 financial results conference call. All participants will be in listen-only mode. Should you need assistance during the conference call, you may signal an operator by pressing star followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star, then one on your telephone keypad. To withdraw yo ...

BETHLEHEM, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering third quarter 2025 financial results and certain business developments for 5 p.m. ET on November 5, 2025. A webcast of the conference call will be available on the investor relations page of OraSure’s website at https://orasure.gcs-web.com/events-and-presentations. Please click on the webcast link and follow the prompts for registration and access at least 1 ...

MENLO PARK, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc., a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that it has launched the roadshow for its proposed initial public offering of 3,846,000 shares of its Class A common stock. In addition, BillionToOne intends to grant the underwriters a 30-day option to purchase up to an additional 576,900 shares of its Class A common stock at the initial public offering pri ...

(Catch all the US News, UK News, Canada News, International Breaking News Events, and Latest News Updates on The Economic Times.) Download The Economic Times News App to get Daily International News Updates. ...

美股市场表现 - 道琼斯指数上涨051%至47,44922点，涨幅超过200点 [1] - 纳斯达克指数上涨168%至23,59380点 [1] - 标普500指数上涨101%至6,86011点 [1] - 通信服务板块领涨，涨幅达15% [1] - 公用事业板块下跌04% [1] 个股重大变动 - Carter's Inc (CRI) 股价上涨5%，公司第三季度每股收益074美元，超出分析师共识估计073美元，季度销售额757836百万美元，低于分析师共识估计769763百万美元 [2] - Sotherly Hotels Inc (SOHO) 股价飙升137%至215美元，公司同意被Kemmons Wilson Hospitality Partners LP附属公司牵头的合资企业收购 [7] - Co-Diagnostics, Inc (CODX) 股价大涨102%至07104美元，公司与Arabian Eagle签署最终协议，共同成立CoMira Diagnostics [7] - BIO-key International, Inc (BKYI) 股价上涨115%至16750美元，公司与斯堪的纳维亚主要IT安全分销商IT2Trust建立合作伙伴关系 [7] - Intellia Therapeutics, Inc (NTLA) 股价下跌43%至1471美元，公司宣布暂时停止对Nex-z药物的MAGNITUDE和MAGNITUDE-2三期临床研究进行患者给药和筛查 [7] - Organon & Co (OGN) 股价下跌20%至729美元，公司首席执行官Kevin Ali因审计委员会调查而辞职 [7] - Genenta Science SpA (GNTA) 股价下跌43%至35268美元，公司宣布定价1500万美元的美国存托凭证定向增发 [7] 商品市场 - 原油价格上涨01%至6158美元 [6] - 黄金价格下跌31%至4,00990美元 [6] - 白银价格下跌38%至46755美元 [6] - 铜价格上涨09%至51690美元 [6] 全球其他市场 - 欧洲斯托克600指数上涨017%，西班牙IBEX 35指数上涨082%，英国富时100指数上涨015%，德国DAX指数上涨016%，法国CAC 40指数上涨007% [7][8] - 日本日经225指数上涨246%，香港恒生指数上涨105%，中国上证综指上涨118%，印度孟买Sensex指数上涨067% [9] 公司财报与展望 - Carter's Inc 预计新行政关税将带来重大财务影响，年度化税前收益影响约为2亿至25亿美元，高于2024财年支付的11亿美元关税 [2][3] 经济数据 - 达拉斯联储制造业指数将于当日发布 [10]

美股市场表现 - 纳斯达克综合指数上涨超过300点，涨幅达1.37%至23,521.66点 [1] - 道琼斯工业平均指数上涨0.41%至47,398.49点 [1] - 标普500指数上涨0.82%至6,847.22点 [1] 行业板块表现 - 信息技术股领涨，涨幅达1.5% [1] - 必需消费品股下跌0.3% [2] 个股重大消息 - Keurig Dr Pepper Inc (KDP) 股价大涨约6%，公司第三季度净销售额达到43.1亿美元，同比增长10.7%，超出市场预期的41.5亿美元，并上调了全年销售指引 [3][4] - Sotherly Hotels Inc (SOHO) 股价飙升137%至2.15美元，公司同意被Kemmons Wilson Hospitality Partners附属公司领导的合资企业收购 [10] - Co-Diagnostics Inc (CODX) 股价大涨133%至0.8163美元，公司与Arabian Eagle签署最终协议，在中东地区建立CoMira Diagnostics并本地化其Co-Dx PCR平台 [10] - BIO-key International Inc (BKYI) 股价上涨110%至1.64美元，公司与斯堪的纳维亚主要IT安全分销商IT2Trust建立合作伙伴关系 [10] - Intellia Therapeutics Inc (NTLA) 股价下跌42%至14.92美元，公司宣布暂时停止Nex-z针对转甲状腺素蛋白淀粉样变性心肌病患者的MAGNITUDE和MAGNITUDE-2三期临床研究的患者给药和筛查 [10] - Smart Logistics Global Limited (SLGB) 股价下跌43%至2.93美元 [10] - Genenta Science SpA (GNTA) 股价下跌42%至3.5902美元，公司宣布定价1500万美元的美国存托凭证定向增发 [10] 商品市场 - 原油价格下跌0.1%至每桶61.44美元 [7] - 黄金价格下跌2.1%至每盎司4,051.80美元 [7] - 白银价格下跌2.3%至每盎司47.455美元 [7] - 铜价上涨0.8%至每磅5.1615美元 [7] 全球其他市场 - 欧洲斯托克600指数上涨0.1%，西班牙IBEX 35指数上涨0.6%，英国富时100指数上涨0.1%，德国DAX 40指数下跌0.1%，法国CAC 40指数下跌0.1% [8] - 日本日经225指数上涨2.46%，香港恒生指数上涨1.05%，中国上证综合指数上涨1.18%，印度孟买Sensex指数上涨0.67% [11] 经济数据 - 达拉斯联储制造业指数将于当日发布 [12]

DUBLIN, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced that the Company welcomes the indicated intention of its largest investor and primary lender, Perceptive Advisors, to submit a proposal that, if implemented, would facilitate the conversion of a portion of the Company’s outstanding debt and other obligations into equity. The Compan ...

Co-Diagnostics, Inc. (NASDAQ:CODX) announced on Monday that it has entered into a joint venture agreement with the Kingdom of Saudi Arabia (KSA) based Arabian Eagle Manufacturing. The agreement aims to research, develop, manufacture, assemble, distribute, and commercialize Co-Dx technologies and intellectual property, including the company's upcoming Co-Dx PCR point-of-care platform in KSA and 18 other countries across the Middle East and North Africa regions. The financial terms of the JV were not disclo ...

FRIENDSWOOD, Texas, Oct. 26, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data demonstrating that its TissueCypher® Barrett’s Esophagus test can provide risk insights beyond pathology alone, influencing clinical management to support earlier intervention for those at higher risk of progression to esophageal cancer and potentially reducing unnecessary procedures for those at lower risk. The r ...

This new histological subtype data confirms DecisionDx-Melanoma’s clinical value across the spectrum of melanoma Castle Biosciences will also present validation data on its atopic dermatitis pipeline test FRIENDSWOOD, Texas, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it is presenting data on its DecisionDx®-Melanoma test and its pipeline atopic dermatitis (AD) gene expression pro ...